Acta Biochim Biophys Sin (Shanghai)

1. JIN S, Wang W, Xu X, Yu Z, et al
   miR-34b-3p-mediated regulation of STC2 and FN1 enhances chemosensitivity and inhibits proliferation in cervical cancer.
   Acta Biochim Biophys Sin (Shanghai). 2024 Mar 13. doi: 10.3724/abbs.2024009.
   

   >> Share

   
   

   
   Altern Ther Health Med

2. LU D, Chen X, Mu Y, Guo J, et al
   Clinical Efficacy of Sodium Cantharidate Vitamin B6 Combined with Concurrent Chemoradiotherapy in the Treatment of Local Advanced Cervical Cancer and its Influence on Tumor Markers.
   Altern Ther Health Med. 2024 Mar 8:AT10236.
   

   >> Share

   
   

   
   Am J Clin Oncol

3. CHEN F, Gong X, Zhang K, Yu Y, et al
   Nomogram Predicting Grade >/=2 Acute Radiation Enteritis in Patients With Cervical Cancer Receiving Concurrent Chemoradiotherapy.
   Am J Clin Oncol. 2024 Mar 15. doi: 10.1097/COC.0000000000001096.
   

   >> Share

   
   

   
   Am J Transl Res

4. HU H, Wang Z, Xue L, Zhang T, et al
   Effects of neoadjuvant chemotherapy combined with radical laparoscopic surgery with quality nursing care on clinical efficacy and sex hormones in patients with cervical cancer.
   Am J Transl Res. 2024;16:477-486.
   

   >> Share

   
   

   
   Asian J Surg

5. LI Z, Qiu W, Dong J, Ying X, et al
   Colon metastasis from malignant mullerian tumor of uterine cervix: A case report.
   Asian J Surg. 2024;47:1393-1394.
   

   >> Share

   
   

   
   BMC Public Health

6. GEBREEGZIABHER ZA, Semagn BE, Kifelew Y, Abebaw WA, et al
   Cervical cancer screening and its associated factors among women of reproductive age in Kenya: further analysis of Kenyan demographic and health survey 2022.
   BMC Public Health. 2024;24:741.
   

   >> Share

   
   

   
   BMJ

7. SHELTON J, Zotow E, Smith L, Johnson SA, et al
   25 year trends in cancer incidence and mortality among adults aged 35-69 years in the UK, 1993-2018: retrospective secondary analysis.
   BMJ. 2024;384:e076962.
   

   >> Share

   
   

   
   Brachytherapy

8. MATSUDA Y, Nagamine Y, Irie T, Goto T, et al
   Effects of pain management using nonsteroidal anti-inflammatory drug suppositories during brachytherapy for cervical cancer: A single-center prospective observational study.
   Brachytherapy. 2024 Mar 9:S1538-4721(24)00003.
   

   >> Share

   
   

   
   Cancer Biol Ther

9. HAN L, Liu J, Shataer M, Wu C, et al
   The relationship between long non-coding gene CASC21 polymorphisms and cervical cancer.
   Cancer Biol Ther. 2024;25:2322207.
   

   >> Share

   
   

   
   Cancer Control

10. IQBAL L, Jehan M, Azam S
    Advancements in mRNA Vaccines: A Promising Approach for Combating Human Papillomavirus-Related Cancers.
    Cancer Control. 2024;31:10732748241238629.
    

    >> Share

    
    

    
    Cancer Lett

11. CAO C, Xu Q, Zhu Z, Xu M, et al
    Three-dimensional chromatin analysis reveals Sp1 as a mediator to program and reprogram HPV-host epigenetic architecture in cervical cancer.
    Cancer Lett. 2024 Mar 10:216809. doi: 10.1016/j.canlet.2024.216809.
    

    >> Share

    
    

    
    Cancers (Basel)

12. EUSTACE N, Liu J, Ladbury C, Tam A, et al
    Current Status and Future Directions of Image-Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer.
    Cancers (Basel). 2024;16:1031.
    

    >> Share

    
    

    
    Chem Biodivers

13. PEREIRA MTM, Charret TS, Wermelinger GF, Nogueira TSR, et al
    Evaluation of the Antiproliferative Potential of yellow Jaboticaba (Myrciaria glazioviana) extracts against Human Cervical Cancer (HeLa cells line) and the Analysis of their Chemical Composition by HPLC-HRESIMS.
    Chem Biodivers. 2024 Mar 12:e202301467. doi: 10.1002/cbdv.202301467.
    

    >> Share

    
    

    
    Clin Epigenetics

14. SINHA A, Ghosh A, Ghosh A, Mathai S, et al
    MAL expression downregulation through suppressive H3K27me3 marks at the promoter in HPV16-related cervical cancers is prognostically relevant and manifested by the interplay of novel MAL antisense long noncoding RNA AC103563.8, E7 oncoprotein and EZH2
    Clin Epigenetics. 2024;16:40.
    

    >> Share

    
    

    
    Cureus

15. PALAGUDI M, Para S, Golla N, Meduri KC, et al
    Adverse Effects of Cancer Treatment in Patients With Cervical Cancer.
    Cureus. 2024;16:e54106.
    

    >> Share

    
    
16. OTSUKA I
    Peritoneal Recurrence of Squamous Cell Carcinoma in a Young Woman After Conization for Microinvasive Cervical Cancer.
    Cureus. 2024;16:e54091.
    

    >> Share

    
    
17. PATEL D, Tayade S, Singh Thakur A, Singh S, et al
    Revolutionizing Early-Stage Cervical Cancer Treatment: A Comprehensive Review of Radical Trachelectomy as a Minimally Invasive Approach.
    Cureus. 2024;16:e53958.
    

    >> Share

    
    

    
    Dermatol Online J

18. GOCIMAN S, Florell SR, Clarke JT
    Cutaneous metastasis as a first sign of adenocarcinoma of the cervix.
    Dermatol Online J. 2023;29.
    

    >> Share

    
    

    
    Discov Oncol

19. MEI J, Pan L, Huang M, Bao D, et al
    DDOST is associated with tumor immunosuppressive microenvironment in cervical cancer.
    Discov Oncol. 2024;15:69.
    

    >> Share

    
    

    
    Eur J Obstet Gynecol Reprod Biol

20. ALVES FIRMEZA M, de Vasconcelos Oliveira NM, Mendes Alves F, Teixeira Moreira Vasconcelos C, et al
    Urinary symptoms and sexual function after hysterectomy secondary to cervical cancer: A prospective, cohort study.
    Eur J Obstet Gynecol Reprod Biol. 2024;296:208-214.
    

    >> Share

    
    

    
    Eur J Oncol Nurs

21. DONG Y, Jiang G, Qu H, Zhuang H, et al
    Effectiveness of a narrative nursing intervention on reproductive concerns in women of childbearing age undergoing cervical cancer surgery: A randomized controlled trial.
    Eur J Oncol Nurs. 2024;70:102537.
    

    >> Share

    
    

    
    Eur J Surg Oncol

22. TALIENTO C, Scutiero G, Arcieri M, Pellecchia G, et al
    Simple hysterectomy versus radical hysterectomy in early-stage cervical cancer: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2024;50:108252.
    

    >> Share

    
    
23. FAROOQI HA, Nabi R
    Enhancing cervical cancer surveillance: Utilizing inflammatory markers for improved recurrence detection in low-resource settings and a call for prospective multi-centric studies.
    Eur J Surg Oncol. 2024 Mar 1:108239. doi: 10.1016/j.ejso.2024.108239.
    

    >> Share

    
    
24. KE Y, Zhang Z, Li Y, Qin Y, et al
    Prognostic value of lymph node ratio in patients with non-metastatic cervical cancer treated with radical hysterectomy: A population-based study.
    Eur J Surg Oncol. 2024;50:108258.
    

    >> Share

    
    
25. BIZZARRI N, Fedele C, Teodorico E, Certelli C, et al
    Survival associated with the use of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node metastasis in cervical cancer.
    Eur J Surg Oncol. 2024;50:108250.
    

    >> Share

    
    

    
    Exp Ther Med

26. FENG J, Wang T
    [Retracted] MicroRNA?873 serves a critical role in human cervical cancer proliferation and metastasis via regulating glioma?associated oncogene homolog 1.
    Exp Ther Med. 2024;27:163.
    

    >> Share

    
    

    
    Front Cell Infect Microbiol

27. MA C, Zou M, Xu N, Liu Y, et al
    Portable, and ultrasensitive HR-HPV tests based on nucleic acid biosensors.
    Front Cell Infect Microbiol. 2024;14:1357090.
    

    >> Share

    
    

    
    Front Immunol

28. LIN Z, Li X, Shi H, Cao R, et al
    Decoding the tumor microenvironment and molecular mechanism: unraveling cervical cancer subpopulations and prognostic signatures through scRNA-Seq and bulk RNA-seq analyses.
    Front Immunol. 2024;15:1351287.
    

    >> Share

    
    
29. LI C, Hua K
    Corrigendum: Dissecting the single-cell transcriptome network of immune environment underlying cervical premalignant lesion, cervical cancer and metastatic lymph nodes.
    Front Immunol. 2024;15:1386072.
    

    >> Share

    
    

    
    Front Oncol

30. SHIMELS T, Gashawbeza B, Gedif Fenta T
    Access to advanced healthcare services and its associated factors among patients with cervical cancer in Addis Ababa, Ethiopia.
    Front Oncol. 2024;14:1342236.
    

    >> Share

    
    
31. LEE F, McGue S, Chapola J, Dunda W, et al
    Experiences of women participating in a human papillomavirus-based screen-triage-and treat strategy for cervical cancer prevention in Malawi.
    Front Oncol. 2024;14:1356654.
    

    >> Share

    
    

    
    Gynecol Minim Invasive Ther

32. 
    Erratum: A Comparison of Conventional Pap Smear and Liquid-Based Cytology for Cervical Cancer Screening.
    Gynecol Minim Invasive Ther. 2024;13:68.
    

    >> Share

    
    
33. LIU CK, Huang KG, Chen MJ, Lu CH, et al
    The Current Trend of Fertility Preservation in Patients with Cervical Cancer.
    Gynecol Minim Invasive Ther. 2023;13:4-9.
    

    >> Share

    
    

    
    Hawaii J Health Soc Welf

34. ROBLE JG, Ligon SE, Langan KL
    Leukocytoclastic Vasculitis Localized to the Uterine Cervix.
    Hawaii J Health Soc Welf. 2024;83:81-84.
    

    >> Share

    
    

    
    Implement Sci

35. OLAKUNDE BO, Itanyi IU, Olawepo JO, Liu L, et al
    Comparative effectiveness of implementation strategies for Accelerating Cervical Cancer Elimination through the integration of Screen-and-treat Services (ACCESS study): protocol for a cluster randomized hybrid type III trial in Nigeria.
    Implement Sci. 2024;19:25.
    

    >> Share

    
    

    
    Int J Gynecol Cancer

36. WESS B, Kohler C, Plaikner A, El-Safadi S, et al
    Comparative study using indocyanine green and patent blue dye for sentinel lymph node biopsy in patients with early-stage cervical cancer.
    Int J Gynecol Cancer. 2024 Mar 14:ijgc-2023-005206.
    

    >> Share

    
    
37. DEL M, Illac C, Morisseau M, Angeles MA, et al
    Intraepithelial tumor-infiltrating lymphocytes shape loco-regional PET/CT spread of locally advanced cervical cancer.
    Int J Gynecol Cancer. 2024 Mar 12:ijgc-2023-004677.
    

    >> Share

    
    

    
    Int J Hyperthermia

38. MINGO BARBA S, Ademaj A, Marder D, Riesterer O, et al
    Theoretical evaluation of the impact of diverse treatment conditions by calculation of the tumor control probability (TCP) of simulated cervical cancer Hyperthermia-Radiotherapy (HT-RT) treatments in-silico.
    Int J Hyperthermia. 2024;41:2320852.
    

    >> Share

    
    

    
    Int J Mol Sci

39. WATTANATHAVORN W, Seki M, Suzuki Y, Buranapraditkun S, et al
    Downregulation of LAMB3 Altered the Carcinogenic Properties of Human Papillomavirus 16-Positive Cervical Cancer Cells.
    Int J Mol Sci. 2024;25:2535.
    

    >> Share

    
    

    
    Int J Radiat Oncol Biol Phys

40. GEORGE J, Tuli S, Patel PP, Monare B, et al
    Delays in cervical cancer treatment initiation for patients living with or without HIV in Botswana: An observational cohort analysis (2015-2019).
    Int J Radiat Oncol Biol Phys. 2024 Mar 8:S0360-3016(24)00354.
    

    >> Share

    
    

    
    Int J Womens Health

41. ZHAO M, Gao MZ, Gu RY, Luo L, et al
    The Risk of Cervical Cancer in Women Among Han, Bai, Dai and Hani Ethnic Minorities in Yunnan Province of China.
    Int J Womens Health. 2024;16:373-384.
    

    >> Share

    
    

    
    Investig Clin Urol

42. CHOI CI, Lee SJ, Choi JB, Kim TH, et al
    2023 Korean sexually transmitted infections guidelines by the Korean Association of Urogenital Tract Infection and Inflammation: Human papillomavirus vaccination.
    Investig Clin Urol. 2024;65:108-114.
    

    >> Share

    
    

    
    IUBMB Life

43. 
    Retraction: miR-212/132 downregulates SMAD2 expression to suppress the G1/S phase transition of the cell cycle and the epithelial to mesenchymal transition in cervical cancer cells.
    IUBMB Life. 2024 Mar 14. doi: 10.1002/iub.2815.
    

    >> Share

    
    

    
    J Clin Epidemiol

44. BRENTNALL AR, Cuschieri K, Sargent A, Berkhof J, et al
    Staged design recommendations for validating relative sensitivity of self-sample human papillomavirus tests for cervical screening.
    J Clin Epidemiol. 2024;166:111227.
    

    >> Share

    
    

    
    J Community Health

45. TSEGAYE AT, Lin J, Cole A, Szpiro AA, et al
    Association of Maternal Cervical Cancer Screening Adherence with Adolescent HPV Vaccination Among Adolescent-Mother Pairs.
    J Community Health. 2024 Mar 14. doi: 10.1007/s10900-024-01333.
    

    >> Share

    
    

    
    J Family Med Prim Care

46. YADAV P, Gaurav A, Ravi AK, Khoiwal K, et al
    Cervical cancer awareness, knowledge, behavioural patterns, and practice of screening and vaccination in females of hilly regions of North India - A hospital-based observational study.
    J Family Med Prim Care. 2024;13:43-47.
    

    >> Share

    
    

    
    J Immigr Minor Health

47. MOHAMED AA, Shah V, Njeru JW, Wieland ML, et al
    Interventions to Increase Cancer Screening Adherence Among Somali Immigrants in the US and Europe: A Systematic Review.
    J Immigr Minor Health. 2024;26:385-394.
    

    >> Share

    
    

    
    J Infect Dis

48. ARTHUR AW, El-Zein M, Burchell AN, Tellier PP, et al
    Detection and Clearance of Type-Specific and Phylogenetically Related Genital Human Papillomavirus Infections in Young Women in New Heterosexual Relationships.
    J Infect Dis. 2024;229:691-706.
    

    >> Share

    
    

    
    J Low Genit Tract Dis

49. ALTINOK P, Ergen SA, Guzeloz Capar Z, Canyilmaz E, et al
    Awareness Level of Cervical Cancer Patients Referred to Radiation Oncology Outpatient Clinics-A Multicenter Study.
    J Low Genit Tract Dis. 2024 Mar 5. doi: 10.1097/LGT.0000000000000798.
    

    >> Share

    
    

    
    J Magn Reson Imaging

50. ARKOUDIS NA, Kelekis NL
    Editorial for "Deep Learning Nomogram for the Identification of Deep Stromal Invasion in Patients With Early-Stage Cervical Adenocarcinoma and Adenosquamous Carcinoma: A Multicenter Study".
    J Magn Reson Imaging. 2024;59:1407-1408.
    

    >> Share

    
    
51. XIAO ML, Qian T, Fu L, Wei Y, et al
    Deep Learning Nomogram for the Identification of Deep Stromal Invasion in Patients With Early-Stage Cervical Adenocarcinoma and Adenosquamous Carcinoma: A Multicenter Study.
    J Magn Reson Imaging. 2024;59:1394-1406.
    

    >> Share

    
    

    
    J Med Virol

52. SHALABY NA, Tudorescu-Morjan C, Manole CG, Iacata AA, et al
    Correlation between high-risk HPV infection and p16/Ki-67 abnormalities in Pap samples in a South Eastern Europe cohort.
    J Med Virol. 2024;96:e29524.
    

    >> Share

    
    

    
    J Obstet Gynaecol

53. LIN YX, Zhao FF, Kong WM
    Effects of vaginal dilation therapy on vaginal length, vaginal stenosis, vaginal elasticity and sexual function of cervical cancer survivors.
    J Obstet Gynaecol. 2024;44:2317387.
    

    >> Share

    
    

    
    J Racial Ethn Health Disparities

54. HALD SR, Tatari CR, Kirkegaard P, Tranberg M, et al
    "Well, that Was Pretty Clever!"-Ethnic Minority Women's Views on HPV Self-Sampling Devices for Cervical Cancer Screening: Attitudes to Brushes, First-Void Urine, and Menstrual Blood Devices.
    J Racial Ethn Health Disparities. 2024 Mar 12. doi: 10.1007/s40615-024-01963.
    

    >> Share

    
    

    
    J UOEH

55. KURATSUNE K, Ueda T, Tajiri R, Tohyama A, et al
    [A Case of Adenocarcinoma, HPV-independent, Mesonephric Type with Significant Response to Neoadjuvant Chemotherapy].
    J UOEH. 2024;46:45-51.
    

    >> Share

    
    

    
    Magn Reson Imaging

56. XIAO Y, Chen W, Long X, Li M, et al
    3D MR elastography-based stiffness as a marker for predicting tumor grade and subtype in cervical cancer.
    Magn Reson Imaging. 2024 Mar 12:S0730-725X(24)00062.
    

    >> Share

    
    

    
    Mol Biol Rep

57. SETAYESHI S, Hasanzadeh A, Yahyapour Y, Alizadeh A, et al
    Evaluation of human papillomavirus type 16 viral load and genome physical status in Iranian women with cervical disease.
    Mol Biol Rep. 2024;51:411.
    

    >> Share

    
    

    
    Molecules

58. FELIX MM, Tavares MV, Santos IP, Batista de Carvalho ALM, et al
    Cervical Squamous Cell Carcinoma Diagnosis by FTIR Microspectroscopy.
    Molecules. 2024;29:922.
    

    >> Share

    
    

    
    Mutagenesis

59. ZHAO F, Zhou W, Xin R, Miao X, et al
    Expression and clinical diagnostic value of CCHE1 in breast cancer.
    Mutagenesis. 2024;39:141-145.
    

    >> Share

    
    

    
    Nat Commun

60. LONG J, Chen X, He M, Ou S, et al
    HLA-class II restricted TCR targeting human papillomavirus type 18 E7 induces solid tumor remission in mice.
    Nat Commun. 2024;15:2271.
    

    >> Share

    
    

    
    Obstet Gynecol Sci

61. HWANG WY, Choi CH, Kim K, Kim MH, et al
    Determination of ovarian transposition through prediction of postoperative adjuvant therapy in young patients with early stage cervical cancer undergoing surgery: a Korean multicenter retrospective study (KGOG 1042).
    Obstet Gynecol Sci. 2024 Mar 14. doi: 10.5468/ogs.23291.
    

    >> Share

    
    

    
    Oncol Lett

62. WANG P, Gao D, Yu X, Zhu G, et al
    Value of high?risk human papillomavirus detection combined with colposcopy in the diagnosis of cervical cancer and precancerous lesions.
    Oncol Lett. 2024;27:185.
    

    >> Share

    
    

    
    PLOS Glob Public Health

63. LAMICHHANE B, Adhikari B, Poudel L, Pandey AR, et al
    Factors associated with uptake of breast and cervical cancer screening among Nepalese women: Evidence from Nepal Demographic and Health Survey 2022.
    PLOS Glob Public Health. 2024;4:e0002971.
    

    >> Share

    
    
64. DAU H, Nankya E, Naguti P, Basemera M, et al
    The economic burden of cervical cancer on women in Uganda: Findings from a cross-sectional study conducted at two public cervical cancer clinics.
    PLOS Glob Public Health. 2024;4:e0002554.
    

    >> Share

    
    

    
    PLoS Negl Trop Dis

65. MBWANJI G, Mazigo HD, Maganga JK, Downs JA, et al
    Female genital schistosomiasis is a neglected public health problem in Tanzania: Evidence from a scoping review.
    PLoS Negl Trop Dis. 2024;18:e0011954.
    

    >> Share

    
    

    
    Radiat Oncol

66. DONG EE, Xu J, Kim JW, Bryan J, et al
    Apparent diffusion coefficient values predict response to brachytherapy in bulky cervical cancer.
    Radiat Oncol. 2024;19:35.
    

    >> Share

    
    

    
    Radiother Oncol

67. KUIPERS SC, Godart J, Corbeau A, Breedveld S, et al
    Dosimetric impact of bone marrow sparing for robustly optimized IMPT for locally advanced cervical cancer.
    Radiother Oncol. 2024 Mar 10:110222. doi: 10.1016/j.radonc.2024.110222.
    

    >> Share

    
    

    
    Redox Biol

68. MENG Q, Zhang Y, Sun H, Yang X, et al
    Human papillomavirus-16 E6 activates the pentose phosphate pathway to promote cervical cancer cell proliferation by inhibiting G6PD lactylation.
    Redox Biol. 2024;71:103108.
    

    >> Share

    
    

    
    Reprod Sci

69. LUO Y, Liu Z, Hu X
    ceRNA Network and WGCNA Analyses of Differentially Expressed Genes in Cervical Cancer Tissues for Association with Survival of Patients.
    Reprod Sci. 2024 Mar 11. doi: 10.1007/s43032-024-01477.
    

    >> Share

    
    

    
    Sci Rep

70. DONG X, Zhan Y, Li S, Yang M, et al
    MKRN1 regulates the expression profiles and transcription factor activity in HeLa cells inhibition suppresses cervical cancer cell progression.
    Sci Rep. 2024;14:6129.
    

    >> Share

    
    

    
    Urogynecology (Phila)

71. CHAPMAN HL, Dholakia JJ, Marcrom S, Liang M, et al
    Treatment of Cervical Cancer Complicated by Advanced Pelvic Organ Prolapse: A Case Report.
    Urogynecology (Phila). 2024;30:309-313.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share